Nurse Promotion of IV to PO Antimicrobial Conversion
FERN-IPO
Fostering Engagement From Nurses in Promoting IV to PO Antimicrobial Conversion: The FERN-IPO Study
1 other identifier
interventional
853
1 country
1
Brief Summary
This is a prospective, quasi-experimental, historically controlled study to evaluate if a behavioural change intervention informed by the COM-B model of behaviour change can improve nurses' self-perceived capability, opportunity, and motivation to engage in the assessment of patients who may be appropriate for IV to PO antimicrobial conversion. This study also seeks to determine if this translates into an increase in IV to PO antimicrobial conversion rates in the acute care setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 29, 2018
CompletedFirst Posted
Study publicly available on registry
December 3, 2018
CompletedStudy Start
First participant enrolled
January 8, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 7, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 7, 2019
CompletedSeptember 6, 2019
September 1, 2019
3 months
November 29, 2018
September 5, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
IV to PO antimicrobial conversion rate
Incidence of IV to PO antimicrobial conversion (defined as the initiation of a PO antimicrobial within 24 hours of discontinuation of an IV antimicrobial during a single treatment course in a specific patient) before and after behavior change intervention
Six months (three months pre-intervention, three months post-intervention)
Secondary Outcomes (2)
Days of IV therapy prior to conversion to PO antimicrobial
Six months (three months pre-intervention, three months post-intervention)
Nurse perceptions of capability, opportunity and motivation to promote IV to PO antimicrobial conversion
Six months (three months pre-intervention, three months post-intervention)
Other Outcomes (4)
Balancing measure - Failed IV to PO antimicrobial conversion
Six months (three months pre-intervention, three months post-intervention
Subgroup Analysis 1: Nursing Unit Conversion Comparison
Six months (three months pre-intervention, three months post-intervention)
Subgroup Analysis 2: High Bioavailability Antimicrobial Conversion
Six months (three months pre-intervention, three months post-intervention)
- +1 more other outcomes
Study Arms (2)
Pre-Intervention Arm
NO INTERVENTIONThe nurses will have not been exposed to the behavior change intervention.
Post-Intervention Arm
EXPERIMENTALThe nurses will have been exposed to the behavior change intervention.
Interventions
IV to PO antimicrobial conversion guidelines for nurses, nurse in-services and internet education sessions, IV to PO antimicrobial conversion health record reminder, endorsement from antimicrobial stewardship program, prescribers, and nurse educators.
Eligibility Criteria
You may qualify if:
- Nineteen years of age or older
- Employed as a RN or LPN at KGH in any capacity (full-time, part-time or casual employee)
- Practicing on a medicine/thoracic surgery ward (4A) or medicine/oncology/respiratory ward (4B)
You may not qualify if:
- RNs or LPNs on orientation shifts/training
- RNs or LPNs not engaged in patient care
- Student nurses/nurses in training
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kelowna General Hospital
Kelowna, British Columbia, V1Y1T2, Canada
Related Publications (1)
Fisher CC, Cox VC, Gorman SK, Lesko N, Holdsworth K, Delaney N, McKenna C. A theory-informed assessment of the barriers and facilitators to nurse-driven antimicrobial stewardship. Am J Infect Control. 2018 Dec;46(12):1365-1369. doi: 10.1016/j.ajic.2018.05.020. Epub 2018 Aug 1.
PMID: 30077436BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Victoria Cox, PharmD
Interior Health Authority
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Pharmacy Coordinator, Clinical Quality & Research
Study Record Dates
First Submitted
November 29, 2018
First Posted
December 3, 2018
Study Start
January 8, 2019
Primary Completion
April 7, 2019
Study Completion
April 7, 2019
Last Updated
September 6, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share